NASDAQ:RVPHW Reviva Pharmaceuticals (RVPHW) Stock Price, News & Analysis $0.04 0.00 (0.00%) Closing price 10/16/2025 03:52 PM EasternExtended Trading$0.05 +0.01 (+21.75%) As of 10/16/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock About Reviva Pharmaceuticals Stock (NASDAQ:RVPHW) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Reviva Pharmaceuticals alerts:Sign Up Key Stats Today's Range$0.04▼$0.0450-Day Range$0.03▼$0.0952-Week Range$0.02▼$0.78Volume48,485 shsAverage Volume70,089 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage specialty pharmaceutical company committed to developing novel therapies for dermatologic and ophthalmic conditions with high unmet medical need. The company leverages proprietary formulation and drug‐delivery technologies to advance product candidates through preclinical and clinical development, aiming to enhance solubility, stability and bioavailability in topical and ocular applications. Reviva’s pipeline comprises multiple investigational candidates at various stages. Its lead program, RVI-001, is a topical solution designed to treat common plantar warts and is advancing toward late‐stage clinical testing. Additional programs target inflammation‐driven skin disorders and ocular surface diseases, reflecting the company’s strategic focus on conditions with limited approved therapies. Reviva maintains strategic collaborations with contract research and manufacturing organizations to support formulation optimization and scalable production. Headquartered in Palm Beach County, Florida, Reviva Pharmaceuticals conducts its research and development activities primarily in the United States, with clinical trials spanning sites across North America. Since its founding, the company has assembled a team of experts in dermatology, ophthalmology, formulation science and regulatory affairs. Reviva’s common shares trade on the NASDAQ Capital Market under the ticker RVPH, while its warrants trade under the symbol RVPHW.AI Generated. May Contain Errors. Read More Receive RVPHW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RVPHW Stock News HeadlinesReviva to Participate in the 4th Annual Roth Healthcare Opportunities ConferenceOctober 2, 2025 | finance.yahoo.comReviva Pharmaceuticals Holdings (RVPH) Price Target Decreased by 18.61% to 5.95September 30, 2025 | msn.comClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enforcing that means a $5.39 billion pot must be paid out to everyday Americans. See, virtually every AI model is built off stolen data... | Angel Publishing (Ad)Reviva Pharmaceuticals price target lowered to $2 from $5 at MaximAugust 15, 2025 | msn.comReviva Pharmaceuticals reports Q2 EPS (12c) vs. (26c) last yearAugust 14, 2025 | msn.comRVPHW Reviva Pharmaceuticals Holdings, Inc. WT EXP 122525May 30, 2025 | seekingalpha.comRVPH: 1Q:25 ResultsMay 22, 2025 | finance.yahoo.comReviva Pharmaceuticals Reports Q1 2025 Financial ResultsMay 20, 2025 | tipranks.comSee More Headlines RVPHW Stock Analysis - Frequently Asked Questions How have RVPHW shares performed this year? Reviva Pharmaceuticals' stock was trading at $0.1644 on January 1st, 2025. Since then, RVPHW shares have decreased by 75.7% and is now trading at $0.04. How do I buy shares of Reviva Pharmaceuticals? Shares of RVPHW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:RVPHW CIK1742927 WebN/A Phone408-501-8881FaxN/AEmployees5Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:RVPHW) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.